![](https://realtime-host01.com/3cra/flyers/99/361-288-4668.gif)
Prevention of persistent infection and disease caused by HPV Types 6, 11, 16, 18, 31, 33, 45, 52, and 58
In order to be eligible for participation in this trial, the subject must: Type of Participant and Disease Characteristics
- Is a healthy individual who meets all inclusion criteria and none of the exclusion criteria defined in this section. Demographics
- Is male or female, from 12yearsto 14years of age inclusive, at the time of signing the informed consent/assent.
- Has not yet had coitarche and does not plan on becoming sexually active during the vaccination period.